Compare Abbott India with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs PROCTER & GAMBLE HEALTH - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA PROCTER & GAMBLE HEALTH ABBOTT INDIA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 46.5 62.2 74.8% View Chart
P/BV x 15.2 7.7 198.5% View Chart
Dividend Yield % 0.5 6.2 7.3%  

Financials

 ABBOTT INDIA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-19
PROCTER & GAMBLE HEALTH
Dec-18
ABBOTT INDIA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs8,8343,549 248.9%   
Low Rs5,4581,301 419.4%   
Sales per share (Unadj.) Rs1,731.1511.4 338.5%  
Earnings per share (Unadj.) Rs211.961.3 345.8%  
Cash flow per share (Unadj.) Rs219.974.0 297.1%  
Dividends per share (Unadj.) Rs65.00440.00 14.8%  
Dividend yield (eoy) %0.918.1 5.0%  
Book value per share (Unadj.) Rs945.2927.8 101.9%  
Shares outstanding (eoy) m21.2516.60 128.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.14.7 87.1%   
Avg P/E ratio x33.739.6 85.2%  
P/CF ratio (eoy) x32.532.8 99.2%  
Price / Book Value ratio x7.62.6 289.2%  
Dividend payout %30.7717.9 4.3%   
Avg Mkt Cap Rs m151,84840,257 377.2%   
No. of employees `0003.51.1 307.3%   
Total wages/salary Rs m4,3561,313 331.8%   
Avg. sales/employee Rs Th10,555.57,486.7 141.0%   
Avg. wages/employee Rs Th1,249.91,157.6 108.0%   
Avg. net profit/employee Rs Th1,292.2897.2 144.0%   
INCOME DATA
Net Sales Rs m36,7868,490 433.3%  
Other income Rs m1,133244 464.5%   
Total revenues Rs m37,9198,734 434.2%   
Gross profit Rs m6,0471,482 408.2%  
Depreciation Rs m169211 80.1%   
Interest Rs m230-   
Profit before tax Rs m6,9891,514 461.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m2,485563 441.8%   
Profit after tax Rs m4,5031,017 442.6%  
Gross profit margin %16.417.5 94.2%  
Effective tax rate %35.637.1 95.7%   
Net profit margin %12.212.0 102.2%  
BALANCE SHEET DATA
Current assets Rs m27,61015,343 180.0%   
Current liabilities Rs m8,5691,960 437.1%   
Net working cap to sales %51.8157.6 32.8%  
Current ratio x3.27.8 41.2%  
Inventory Days Days6049 123.5%  
Debtors Days Days2728 96.3%  
Net fixed assets Rs m1,0571,209 87.4%   
Share capital Rs m213166 128.0%   
"Free" reserves Rs m19,87315,235 130.4%   
Net worth Rs m20,08615,401 130.4%   
Long term debt Rs m00-   
Total assets Rs m29,40917,595 167.1%  
Interest coverage x311.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x1.30.5 259.2%   
Return on assets %15.45.8 266.1%  
Return on equity %22.46.6 339.4%  
Return on capital %34.910.3 340.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3691,636 22.5%   
Fx outflow Rs m4,9184,368 112.6%   
Net fx Rs m-4,549-2,732 166.5%   
CASH FLOW
From Operations Rs m4,991-1,304 -382.8%  
From Investments Rs m-2,57012,697 -20.2%  
From Financial Activity Rs m-1,428-301 475.2%  
Net Cashflow Rs m99311,093 9.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.8 144.8%  
Indian inst/Mut Fund % 7.9 18.2 43.4%  
FIIs % 0.1 1.0 10.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 29.1 58.8%  
Shareholders   18,270 28,591 63.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   PFIZER  GSK PHARMA  FRESENIUS KABI ONCO.  WYETH  TORRENT PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Over 300 Points Lower; Dow Futures Down by 101 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading up by 357 points, up 0.7% at 49,267 levels.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jan 22, 2021 03:04 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS